Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro (Q106624719)

1

0 references

Catherine Zhengzheng Chen

2

0 references

Manju Swaroop

3

0 references

Miao Xu

4

0 references

Lihui Wang

5

0 references

Juhyung Lee

6

0 references

Amy Qiu Wang

7

0 references

Manisha Pradhan

8

0 references

Natalie Hagen

9

0 references

Lu Chen

10

0 references

Min Shen

11

0 references

Zhiji Luo

12

0 references

Xin Xu

13

0 references

Yue Xu

14

0 references

Wenwei Huang

15

0 references

Wei Zheng

16

0 references

Yihong Ye

A pneumonia outbreak associated with a new coronavirus of probable bat origin

17

0 references

language of work or name

English

0 references

publication date

4 November 2020

0 references

published in

Cell discovery

0 references

volume

6

0 references

issue

1

0 references

page(s)

80

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

A Novel Coronavirus from Patients with Pneumonia in China, 2019

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

SARS-Associated Coronavirus

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

26 April 2021

Virus entry: open sesame

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Structural insights into coronavirus entry

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Mechanisms of coronavirus cell entry mediated by the viral spike protein

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Cell entry mechanisms of SARS-CoV-2

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells.

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

A myosin-7B-dependent endocytosis pathway mediates cellular entry of α-synuclein fibrils and polycation-bearing cargos

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Heparan sulfate proteoglycan as a cell-surface endocytosis receptor

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Transmission of α-synuclein seeds in neurodegenerative disease: recent developments

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Heparan sulfate proteoglycans

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Heparan sulfate and heparin interactions with proteins

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Sodium and chloride concentrations, pH, and depth of airway surface liquid in distal airways

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Tilorone: A Broad-Spectrum Antiviral For Emerging Viruses

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST).

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Actin visualization at a glance

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Interactions of antitumor agents ametantrone∗∗Trade name for the salt of 1,4-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione (Fig. 1, I). Abbreviations: HAQ, ANT; NSC-287513. and mitoxantrone (novatrone)††Trade name for the sa

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Mitoxantrone affects topoisomerase activities in human breast cancer cells

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Receptor usage and cell entry of porcine epidemic diarrhea coronavirus

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglycoproteins

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Distinct conformational states of SARS-CoV-2 spike protein

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Controlling the SARS-CoV-2 spike glycoprotein conformation

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

26 April 2021

Virus entry at a glance

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Tilorone hydrochloride: mode of action

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

26 April 2021

1 reference

https://api.crossref.org/works/10.1038/S41421-020-00222-5